1314024-00-4

Basic information

• Product Name: N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-isoxazole-3-carboxamide
• Synonyms: N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-isoxazole-3-carboxamide
• CAS NO: 1314024-00-4
• Molecular Weight: 404.345
• Mol File: 1314024-00-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-isoxazole-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-isoxazole-3-carboxamide(1314024-00-4)
• EPA Substance Registry System: N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-isoxazole-3-carboxamide(1314024-00-4)

Safety Data

• Hazardous Substances Data: 1314024-00-4(Hazardous Substances Data)

Upstream product

• 709-63-7 1-(4-trifluoromethylphenyl)ethanone 
• 668970-85-2 5-(4-trifluoromethyl-phenyl)-isoxazole-3-carboxylic acid 
• 1484-85-1 3,4-methylenedioxyphenylethylamine 
• 1221821-67-5 ethyl 2-hydroxy-4-oxo-4-[4-(trifluoromethyl)phenyl]-2-butenoate 
• 613240-18-9 5-(4-Trifluoromethyl-phenyl)-isoxazole-3-carboxylic Acid Ethyl Ester 

Relevant articles and documents

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

Growing evidence suggests a role for the endocannabinoid (EC) system, in intestinal inflammation and compounds inhibiting anandamide degradation offer a promising therapeutic option for the treatment of inflammatory bowel diseases. In this paper, we repor